- Home
- CPRX vs LGIH Comparison
CPRX vs LGIH Comparison
Compare CPRX & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- LGIH
- Stock Information
- Founded
- CPRX 2002
- LGIH 2003
- Country
- CPRX United States
- LGIH United States
- Employees
- CPRX N/A
- LGIH N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- LGIH Homebuilding
- Sector
- CPRX Health Care
- LGIH Consumer Discretionary
- Exchange
- CPRX Nasdaq
- LGIH Nasdaq
- Market Cap
- CPRX 2.5B
- LGIH 2.0B
- IPO Year
- CPRX 2006
- LGIH 2013
- Fundamental
- Price
- CPRX $22.78
- LGIH $92.47
- Analyst Decision
- CPRX Strong Buy
- LGIH Hold
- Analyst Count
- CPRX 7
- LGIH 5
- Target Price
- CPRX $32.86
- LGIH $122.00
- AVG Volume (30 Days)
- CPRX 1.4M
- LGIH 216.3K
- Earning Date
- CPRX 02-26-2025
- LGIH 02-25-2025
- Dividend Yield
- CPRX N/A
- LGIH N/A
- EPS Growth
- CPRX 114.68
- LGIH 9.16
- EPS
- CPRX 1.18
- LGIH 8.36
- Revenue
- CPRX $460,482,000.00
- LGIH $2,253,616,000.00
- Revenue This Year
- CPRX $23.98
- LGIH N/A
- Revenue Next Year
- CPRX $18.27
- LGIH $23.37
- P/E Ratio
- CPRX $19.33
- LGIH $11.06
- Revenue Growth
- CPRX 32.17
- LGIH 0.68
- 52 Week Low
- CPRX $13.12
- LGIH $82.94
- 52 Week High
- CPRX $24.27
- LGIH $130.75
- Technical
- Relative Strength Index (RSI)
- CPRX 56.81
- LGIH 49.90
- Support Level
- CPRX $21.23
- LGIH $82.95
- Resistance Level
- CPRX $23.26
- LGIH $89.72
- Average True Range (ATR)
- CPRX 1.14
- LGIH 2.90
- MACD
- CPRX 0.20
- LGIH 1.26
- Stochastic Oscillator
- CPRX 74.85
- LGIH 75.94
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.